Literature DB >> 4117459

Binding of 125 I myelin basic protein by serum and cerebrospinal fluid.

V Lennon, I R Mackay.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4117459      PMCID: PMC1553691     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  22 in total

1.  The in vitro demyelinating activity of sera from guinea pigs sensitized with whole CNS and with purified encephalitogen.

Authors:  F J Seil; G A Falk; M W Kies; E C Alvord
Journal:  Exp Neurol       Date:  1968-12       Impact factor: 5.330

Review 2.  On cerebrospinal fluid immunoglobulin-G (IgG) quotients in multiple sclerosis and other diseases. A review and a new formula to estimate the amount of IgG synthesized per day by the central nervous system.

Authors:  W Tourtellotte
Journal:  J Neurol Sci       Date:  1970-03       Impact factor: 3.181

3.  A method for the electron microscopic study of cerebrospinal fluid sediment.

Authors:  R M Herndon; M Johnson
Journal:  J Neuropathol Exp Neurol       Date:  1970-04       Impact factor: 3.685

4.  Search for anti-encephalitogen antibody in human demyelinative diseases.

Authors:  R P Lisak; R G Heinze; G A Falk; M W Kies
Journal:  Neurology       Date:  1968-01       Impact factor: 9.910

5.  Radioimmunoassay with gel filtration for detecting antibody to basic proteins of myelin.

Authors:  T A McPherson; P R Carnegie
Journal:  J Lab Clin Med       Date:  1968-11

6.  Skin-fixing antibody in experimental allergic encephalomyelitis.

Authors:  G A Falk; R G Heinze; M W Kies; E C Alvord
Journal:  J Immunol       Date:  1968-02       Impact factor: 5.422

7.  In vitro synthesis of IgG by cells from the cerebrospinal fluid in a patient with multiple sclerosis.

Authors:  M Sandberg-Wollheim; O Zettervall; R Müller
Journal:  Clin Exp Immunol       Date:  1969-04       Impact factor: 4.330

8.  Automated sample application for gel filtration.

Authors:  T A McPherson; P R Carnegie
Journal:  Anal Biochem       Date:  1969-08       Impact factor: 3.365

9.  Multiple sclerosis: serum factor producing reversible alterations in bioelectric responses.

Authors:  J A Cerf; G Carels
Journal:  Science       Date:  1966-05-20       Impact factor: 47.728

10.  Relationships between antibodies and experimental allergic encephalomyelitis. V. Antibodies and delayed hypersensitivity in production and prevention of experimental allergic encephalomyelitis.

Authors:  E C Alvord; C M Shaw; R P Lisak; G A Falk; M W Kies
Journal:  Int Arch Allergy Appl Immunol       Date:  1970
View more
  6 in total

1.  IgG synthesis within the brain in multiple sclerosis and subacute sclerosing panencephalitis.

Authors:  P W Ewan; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

Review 2.  Immunopathological comparisons between experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  I R Mackay; P R Carnegie; A S Coates
Journal:  Clin Exp Immunol       Date:  1973-12       Impact factor: 4.330

3.  Circulating antibody to myelin basic protein in relapsing-remitting multiple sclerosis? A comparative group and sequential study by radioimmunoassay.

Authors:  J A Biggins; A Taylor; E A Caspary
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-12       Impact factor: 10.154

4.  Immune response to myelin basic protein in multiple sclerosis.

Authors:  R A Hughes; I Gray; R Clifford-Jones; M Stern
Journal:  Proc R Soc Med       Date:  1977-12

5.  Serum immunoglobulin E level and search for myelin basic protein specific IgE antibodies in patients with multiple sclerosis.

Authors:  A L Barsoum; P G Höher; E K Kuwert
Journal:  Med Microbiol Immunol       Date:  1977-12-27       Impact factor: 3.402

6.  Antibody to myelin basic protein in extracts of multiple sclerosis brain.

Authors:  C C Bernard; V B Randell; L B Horvath; P R Carnegie; I R Mackay
Journal:  Immunology       Date:  1981-07       Impact factor: 7.397

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.